Twin Power for Total Control

 

COMPOSITION

Linagliptin 2.5mg + Metformin HCL 500/1000mg

INDICATION

  • Type 2 Diabetes Mellitus (T2DM) Management
  • DPP-4 Inhibitor
  • Blood Sugar Control
  • Treatment Limitations
  • Prescription-Based Usage

Linovio-M

  • Substantial improvement in glycaemic control without weight gain or increased risk of hypoglycaemia Dinseres Chess Metab. 2011 Jari5-74
  • The complementary mechanisms of Linagliptin and Metformin result in synergistic glucose-lowering effects. Cin Wwe saghts Clb 2015,8
  • Significant improvements in HbA1c and fasting plasma glucose (FPG) compared with metformin alone.
  • Statistically significant A1c reductions in a fixed-dose combination.